What are BioCryst Pharmaceuticals's profit margins?

BioCryst Pharmaceuticals (BCRX) runs a 97.8% gross margin and a -43.1% operating margin, with a -51.7% net margin.

Where do BioCryst Pharmaceuticals's ratios come from?

Every ratio is computed from BioCryst Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

BioCryst Pharmaceuticals BCRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	97.8%+0.5pp	97.3%-1.4pp	98.6%+1.0pp	97.6%+2.2pp
Operating margin	39%+39.5pp	-0.6%+30.7pp	-31.3%+23.5pp	-54.8%+58.3pp
Net margin	30.2%+49.9pp	-19.7%+48.6pp	-68.4%+22.9pp	-91.2%+25.9pp
EBITDA margin	39.1%+39.4pp	-0.3%+30.5pp	-30.8%+23.5pp	-54.3%+58.3pp
Free cash flow margin	39.4%—	——	-29.4%+30.9pp	-60.3%+31.7pp
Returns
Return on assets	52.5%+70.2pp	-17.6%+24.8pp	-42.5%+1.0pp	-43.4%-3.5pp
Efficiency
Asset turnover	1.7×+0.8×	0.9×+0.3×	0.6×+0.1×	0.5×+0.1×
Inventory turnover	0.8×—	——	——	0.3×-0.3×
Liquidity
Current ratio	2.1×-0.6×	2.6×-0.7×	3.3×-1.6×	4.9×-0.6×
Quick ratio	1.9×-0.5×	2.5×-0.8×	3.3×-1.3×	4.6×-0.7×
Cash ratio	0.5×-0.2×	0.7×-0.1×	0.7×-2.1×	2.9×-2.0×
Leverage
Debt-to-assets	0×-0.6×	0.7×+0.1×	0.6×+0.2×	0.4×+0.2×
Net debt / EBITDA	-0.2×—	——	——	——
Interest coverage	4.3×+4.3×	-0×+0.9×	-1×+0.5×	-1.5×+1.5×
Per Share
Book value per share	-$0.55+76.3%	-$2.30+2.8%	-$2.37-49.6%	-$1.58-165%
Valuation
Market capitalization	$1.64B+5.5%	$1.56B+27.0%	$1.23B-42.7%	$2.14B-14.1%
Enterprise value	$1.57B-12.1%	$1.78B+24.3%	$1.43B-31.0%	$2.08B-2.6%
Price / earnings	6.2×—	——	——	——
Price / sales	1.9×-1.6×	3.5×-0.2×	3.7×-4.2×	7.9×-8.0×
EV / EBITDA	4.6×—	——	——	——
EV / sales	1.8×-2.2×	4×-0.4×	4.3×-3.3×	7.7×-5.9×
Free cash flow yield	21%—	——	-7.9%-0.3pp	-7.6%-1.8pp
Earnings yield	16.1%+21.8pp	-5.7%+12.8pp	-18.5%-6.9pp	-11.5%-4.2pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioCryst Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BioCryst Pharmaceuticals's profit margins?: BioCryst Pharmaceuticals (BCRX) runs a 97.8% gross margin and a -43.1% operating margin, with a -51.7% net margin.
Where do BioCryst Pharmaceuticals's ratios come from?: Every ratio is computed from BioCryst Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.